XML 15 R7.htm IDEA: XBRL DOCUMENT v3.25.1
CONDENSED CONSOLIDATED STATEMENTS OF STOCKHOLDERS' EQUITY - USD ($)
shares in Millions, $ in Millions
Total
Common Stock
Capital Surplus
Retained Earnings/(Accumulated Deficit)
Accumulated Other Comprehensive Loss
Beginning balance at Dec. 31, 2023 $ 479.0 $ 3.5 $ 1,031.9 $ (389.1) $ (167.3)
Beginning balance (shares) at Dec. 31, 2023   350.5      
Increase/(Decrease) in Stockholders' Equity [Roll Forward]          
Net income 142.7     142.7  
Stock-based compensation 8.7   8.7    
Common stock dividends and dividend equivalents declared (81.9)     (81.9)  
Repurchase and retirement of common shares (156.8) $ (0.1)   (156.7)  
Repurchase and retirement of common shares (shares)   (12.3)      
Shares issued under stock-based compensation plans (shares)   1.4      
Other comprehensive income/(loss) (Note 8) 6.2       6.2
Ending balance at Mar. 31, 2024 397.9 $ 3.4 1,040.6 (485.0) (161.1)
Ending balance (shares) at Mar. 31, 2024   339.6      
Beginning balance at Dec. 31, 2024 $ 968.9 $ 3.4 1,070.8 35.2 (140.5)
Beginning balance (shares) at Dec. 31, 2024 337.9 337.9      
Increase/(Decrease) in Stockholders' Equity [Roll Forward]          
Net income $ 123.5     123.5  
Stock-based compensation 10.6   10.6    
Common stock dividends and dividend equivalents declared (80.5)     (80.5)  
Repurchase and retirement of common shares (81.7) $ (0.1)   (81.6)  
Repurchase and retirement of common shares (shares)   (7.5)      
Shares issued under stock-based compensation plans (shares)   1.7      
Other comprehensive income/(loss) (Note 8) (1.4)       (1.4)
Ending balance at Mar. 31, 2025 $ 939.4 $ 3.3 $ 1,081.4 $ (3.4) $ (141.9)
Ending balance (shares) at Mar. 31, 2025 332.1 332.1